Selpercatinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Receptor tyrosine kinase inhibitor owl:NamedIndividual Nitrile Orphan drug Pyridine Tissue agnostic antineoplastic agent Drug granted breakthrough therapy designation
rdfs:label	Selpercatinib
owl:sameAs	dbr:Selpercatinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Nitriles http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Pyridines http://en.wikipedia.org/wiki/Priority_review http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Tissue_agnostic_antineoplastic_agents http://en.wikipedia.org/wiki/Category:Receptor_tyrosine_kinase_inhibitors
skos:prefLabel	Selpercatinib
skos:altLabel	selpercatinib
clgo:alternativeName	Retevmo, Retsevmo
clgo:casNumber	2152628-33-4
clgo:chEMBL	4559134
clgo:class	Tyrosine kinase inhibitor
clgo:drugbank	DB15685
clgo:fdaUniiCode	CEGM9YBNGD
clgo:kegg	D11713
clgo:medlinePlus	a620036
clgo:pubchem	134436906

About: clgr:Selpercatinib